An Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy Subjects

NCT01652859 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Normal Healthy Subjects

Interventions

DRUG: Liposomal Amphotericin B
DRUG: AmBisome

Sponsor

Taiwan Liposome Company